USPTO 2015–2025 USPTO PatentsView US Corporation

CP Kelco U.S., Inc.

USPTO PatentsView assignee record - 17 granted patents across 13 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C08B (POLYSACCHARIDES; Derivatives Thereof).

RSS updates for this company

The verdict

According to USPTO PatentsView, CP ranks #16,707 of 49,997 tracked US assignees by granted-patent volume, with 17 patents across 13 technology areas.

#16,707
of 49,997 US assignees by volume
Top 47%
by Innovation Score (36.4/100)
17.2
avg claims per patent
-77%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R16707 · US Corporation #16,707 · 17 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 17 grants
  • MID-PACK #16,707/49,997
  • PHOTO-FINISH Compugroup Medical SE
  • CPC-FOCUS C08B · 13 areas
  • INNOV-THIN 36.4/100
  • CLAIMS-RICH 17.2 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -77% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Compugroup Medical SE (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How CP’s 36.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around CP

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows CP's Innovation Score is 36.4/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for CP?

Each dot is one of CP’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). CP’s own 17.2 claims/patent is ABOVE the 16.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

CP vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 16.916.91717.1 101520253035 Granted patents (volume) Avg claims / patent Compugroup Medical SE - 17, 13.35Compugroup Medica…Consumer Lighting (U.S.), LLC - 17, 15.59Consumer Lighting…Conventus Orthopaedics, Inc. - 17, 32.71Conventus Orthopa…Cosemi Technologies, Inc. - 17, 19.35CosemiCpac Systems AB - 17, 15.12Cpac Systems ABCrosstex International, Inc. - 17, 16.12Crosstex Internat…CTL Medical Corporation - 17, 17.82CTL MedicalCtxt PTY Ltd - 17, 17.35Ctxt PTYCP Kelco U.S., Inc. - 17, 17.18CP Kelco U S
CP vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where CP's grants concentrate

CP Kelco U.S., Inc. is a focused PatentsView assignee: 13 CPC subclasses with 47.1% of grants classified under C08B (POLYSACCHARIDES; Derivatives Thereof). Peak complete grant year is 2016 (3 grants) versus a trough of 1 in 2020. By volume, CP sits between Compugroup Medical SE and Ctxt PTY Ltd.

CP's three-year grant acceleration

CP Kelco U.S., Inc. shows 2 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at CP's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows CP holds 17 patents at rank #16,679, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near CP

By rank, the assignees closest to #16,679 in granted patent volume.

Leaders in C08B (Polysaccharides)

Other assignees with the most granted patents in CP's primary technology class.

CP's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 47% higher than 53% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 20152016201720182019202020232025 1
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
CP Kelco U.S., Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 11.8%
2016 3 17.6%
2017 3 17.6%
2018 2 11.8%
2019 3 17.6%
2020 1 5.9%
2023 2 11.8%
2025partial year 1 5.9%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

CP Kelco U.S., Inc.'s patent record in context - here's where to go next.

  • CP Kelco U.S., Inc.'s lead technology class is C08B (POLYSACCHARIDES; Derivatives Thereof), 47.1% of its portfolio - see every assignee active in that class. Explore C08B
  • Ranked #16,707 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare CP Kelco U.S., Inc. against Compugroup Medical SE, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 36.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.